Activity Stream
@moatrx
• 2 weeks ago
Posted a new blog:
UK HR+/HER2- BREAST CANCER HTA STRATEGY MODEL
UK HR+/HER2- BREAST CANCER HTA STRATEGY MODEL
NICE accepts all three CDK4/6 inhibitors as comparators for each other, but none has ever faced exemestane plus everolimus head-to-head.
NICE's technology...
